REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

SIKER-PHARMA kft. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: SIKER-PHARMA kft. Profile Updated: September 26, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Hungarian Download a sample report

SIKER-PHARMA kft. is based in Hungary. The head office is in Budapest. The enterprise operates in the Pharmacies and Drug Stores industry. It was established on May 15, 2017. 8 (2024) employees currently work for SIKER-PHARMA kft.. From the latest financial highlights, SIKER-PHARMA kft. reported a net sales revenue increase of 10.83% in 2024. There was a total growth of 9.6% in SIKER-PHARMA kft.’s total assets over the same period. The enterprise’s net profit margin increased by 2.41% in 2024.

Headquarters
Balazs Bela utca 24-28. Fsz. 12. ajto
Budapest; Budapest; Postal Code: 1094

Contact Details: Purchase the SIKER-PHARMA kft. report to view the information.

Basic Information
Total Employees:
Purchase the SIKER-PHARMA kft. report to view the information.
Registered Capital:
Purchase the SIKER-PHARMA kft. report to view the information.
Financial Auditors:
Purchase the SIKER-PHARMA kft. report to view the information.
Incorporation Date:
May 15, 2017
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Subsidiaries
Pharmaco Es Tarsa Kft.
Company Performance
Financial values in the chart are available after SIKER-PHARMA kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
10.83%▲
Total operating revenue
10.69%▲
Operating profit (EBIT)
100.35%▲
EBITDA
44.66%▲
Net Profit (Loss) for the Period
94.34%▲
Total assets
9.6%▲
Total equity
12.47%▲
Operating Profit Margin (ROS)
2.67%▲
Net Profit Margin
2.41%▲
Return on Equity (ROE)
15.03%▲
Quick Ratio
0.1%▲
Cash Ratio
-0.34%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo